▁There 5.83203125
▁is 1.626953125
▁currently 4.72265625
▁a 1.4619140625
▁severe 5.44140625
▁lack 2.92578125
▁of 0.0206146240234375
▁information 3.65625
▁about 1.4462890625
▁the 0.7919921875
▁effects 3.875
▁of 0.1082763671875
▁op 6.61328125
i 3.775390625
ates 0.028350830078125
. 3.91015625
▁They 5.02734375
▁manage 9.1875
▁pain 2.126953125
▁successfully 6.66796875
, 1.00390625
▁but 0.283447265625
▁the 2.6328125
▁past 8.8984375
▁few 1.150390625
▁dec 1.5859375
ades 3.6597251892089844e-05
▁indicated 9.8828125
▁the 2.80859375
▁growing 3.595703125
▁concern 3.19140625
▁regarding 3.37109375
▁op 1.9833984375
iate 0.40185546875
▁ab 1.3798828125
use 0.0094146728515625
▁in 3.419921875
▁forms 9.8515625
▁of 0.2381591796875
▁over 3.35546875
d 0.0738525390625
ose 0.31982421875
▁and 0.79541015625
▁add 0.52490234375
iction 0.01433563232421875
. 0.09808349609375
▁A 4.12890625
▁more 5.3828125
▁manage 9.1015625
able 0.00284576416015625
▁and 2.099609375
▁sa 2.26171875
fer 0.0001596212387084961
▁alternative 1.9326171875
▁might 4.98046875
▁be 0.2481689453125
▁medical 5.8203125
▁mar 0.386474609375
iju 0.0010805130004882812
ana 4.756450653076172e-05
. 0.61962890625
▁However 4.3359375
, 0.0156707763671875
▁the 1.8798828125
▁legal 3.5546875
▁status 1.0693359375
▁and 3.41015625
▁novel 10.4609375
ty 0.212646484375
▁of 0.1463623046875
▁this 1.8681640625
▁drug 1.962890625
▁do 4.91796875
▁not 0.0391845703125
▁allow 0.98291015625
▁finding 7.9765625
▁a 2.63671875
▁large 3.37890625
▁number 0.97216796875
▁of 0.004169464111328125
▁studies 0.923828125
▁on 1.787109375
▁its 1.1279296875
▁effect 2.193359375
iveness 0.181640625
. 0.6806640625
▁Specifically 8.984375
, 0.08868408203125
▁it 2.787109375
▁concerns 5.34375
▁the 0.99365234375
▁emot 9.828125
ional 0.0372314453125
▁condition 5.36328125
▁of 0.623046875
▁patients 1.1826171875
▁experien 6.1328125
cing 9.5367431640625e-05
▁chron 1.0595703125
ic 0.0005893707275390625
▁pain 0.08697509765625
. 0.386474609375
▁This 3.044921875
▁research 2.75390625
▁paper 2.28125
▁a 1.650390625
ims 0.0002751350402832031
▁to 0.128662109375
▁analyze 2.8046875
▁levels 10.6796875
▁of 0.037017822265625
▁de 1.8427734375
pression 0.055816650390625
▁and 0.67919921875
▁anx 0.1328125
iety 0.0002694129943847656
▁among 1.494140625
▁people 2.515625
▁receiving 4.2109375
▁ther 4.98046875
apy 0.0355224609375
▁by 4.61328125
▁comparing 10.3046875
▁the 1.875
▁effects 2.451171875
▁of 0.0289154052734375
▁ph 5.6328125
arma 0.354736328125
ce 0.01131439208984375
ut 0.0002663135528564453
ical 0.0173492431640625
▁op 1.4140625
io 2.65625
ids 0.09234619140625
▁and 0.501953125
▁MM 4.1953125
. 2.421875
<0x0A> 0.3994140625
Chr 4.12109375
onic 0.00745391845703125
▁pain 0.141845703125
▁is 0.876953125
▁still 6.37890625
▁considered 3.005859375
▁to 1.7548828125
▁be 0.039764404296875
▁an 2.83984375
▁extreme 6.6328125
▁issue 3.474609375
▁among 3.251953125
▁at 9.375
▁least 0.09423828125
▁ 0.348388671875
8 3.80078125
% 1.837890625
▁of 0.050384521484375
▁the 0.7275390625
▁residents 7.52734375
▁of 0.364013671875
▁progress 12.078125
ive 0.12213134765625
▁countries 0.44775390625
. 0.453369140625
▁The 2.078125
▁introduction 6.95703125
▁of 0.014404296875
▁the 3.111328125
▁study 6.71875
▁describes 5.32421875
▁the 0.55810546875
▁apparent 9.1796875
▁link 3.7109375
▁between 0.08013916015625
▁pain 2.134765625
▁and 0.358642578125
▁dem 9.15625
oral 1.4599609375
ization 0.06976318359375
. 0.8271484375
▁Chron 4.58984375
ic 0.00878143310546875
▁pain 0.192138671875
▁is 1.5009765625
▁always 5.421875
▁accompanied 1.544921875
▁by 0.053802490234375
▁negative 3.892578125
▁emot 0.501953125
ional 1.169921875
▁experiences 3.173828125
▁and 2.50390625
▁blocks 11.4375
▁a 2.87890625
▁person 0.75537109375
’ 0.66259765625
s 0.0014362335205078125
▁ability 1.1796875
▁to 0.02301025390625
▁receive 6.49609375
▁joy 3.3515625
▁and 1.6748046875
▁satisfaction 2.353515625
▁from 0.701171875
▁life 0.822265625
. 0.225830078125
▁The 1.9384765625
▁research 2.76171875
▁investig 5.89453125
ates 0.30859375
▁the 0.5146484375
▁development 6.890625
▁of 0.053253173828125
▁de 1.0048828125
pression 0.1514892578125
▁and 0.264892578125
▁anx 0.048919677734375
iety 0.0004925727844238281
▁among 1.142578125
▁patients 0.9794921875
▁receiving 2.26171875
▁ph 3.09765625
arma 0.096923828125
ce 0.003082275390625
ut 1.6570091247558594e-05
ical 0.006038665771484375
▁op 0.69580078125
io 0.262939453125
ids 0.12548828125
▁and 0.7666015625
▁medical 1.177734375
▁mar 0.1038818359375
iju 0.0004916191101074219
ana 2.86102294921875e-05
▁( 2.810546875
MM 0.456298828125
) 1.2490234375
▁as 1.7734375
▁severe 10.3203125
▁pain 0.498046875
kill 2.56640625
ers 0.0002315044403076172
. 0.138427734375
▁It 2.98046875
▁comp 4.20703125
ares 0.006404876708984375
▁the 0.484130859375
▁effic 4.37109375
acy 0.00310516357421875
▁of 0.2132568359375
▁pres 6.453125
cri 2.5
ptions 0.82177734375
▁and 1.3818359375
▁exam 4.65625
ines 0.00708770751953125
▁the 0.59619140625
▁possibility 3.775390625
▁of 0.1256103515625
▁post 9.5
- 0.962890625
tre 1.578125
at 0.00186920166015625
ment 0.0032367706298828125
▁de 1.4560546875
pression 0.053802490234375
. 1.4248046875
<0x0A> 0.462890625
The 0.68798828125
▁study 1.7861328125
▁was 2.466796875
▁conducted 0.59716796875
▁in 1.220703125
▁the 1.416015625
▁form 2.5390625
▁of 0.001583099365234375
▁collection 11.625
▁and 0.68310546875
▁analysis 0.35888671875
▁of 0.010223388671875
▁statistical 3.703125
▁data 0.11444091796875
. 0.79931640625
▁Part 5.109375
icip 0.1767578125
ants 0.058013916015625
▁were 0.67529296875
▁rec 3.85546875
ru 0.0011281967163085938
ited 0.00019156932830810547
▁for 4.12109375
▁six 6.50390625
▁months 0.54248046875
▁at 4.21484375
▁two 2.7265625
▁major 4.015625
▁pain 2.69921875
▁relief 4.203125
▁cent 0.76513671875
ers 0.0281219482421875
▁in 0.7138671875
▁Israel 5.50390625
. 0.300537109375
▁The 1.2421875
▁research 2.27734375
ers 1.3408203125
▁used 2.263671875
▁The 7.359375
▁De 3.177734375
pression 0.024017333984375
▁Module 6.55078125
▁of 0.73828125
▁the 0.2132568359375
▁Pat 3.173828125
ient 0.0104217529296875
▁Health 0.039764404296875
▁Question 0.019622802734375
naire 0.0278472900390625
▁and 2.638671875
▁the 0.82373046875
▁General 1.201171875
ized 0.6875
▁An 0.005069732666015625
x 0.0001163482666015625
iety 0.0003962516784667969
▁Dis 0.133056640625
order 0.0215301513671875
▁Sc 1.4619140625
ale 0.002719879150390625
▁to 0.86376953125
▁interview 7.546875
▁participants 2.646484375
, 4.4921875
▁evaluate 4.46484375
▁their 0.58056640625
▁answers 4.14453125
, 0.257080078125
▁and 0.029510498046875
▁conduct 4.90234375
▁the 1.8916015625
▁study 2.306640625
. 0.10284423828125
▁To 4.96875
▁specifically 10.078125
▁evaluate 3.451171875
▁and 5.1953125
▁compare 0.517578125
▁the 0.423095703125
▁prob 9.8671875
abilities 0.039947509765625
▁of 0.0689697265625
▁de 0.91845703125
pression 0.03302001953125
▁or 4.45703125
▁anx 0.047149658203125
iety 0.0005350112915039062
▁among 1.568359375
▁the 2.1328125
▁diverse 9.40625
▁groups 0.80078125
, 0.68505859375
▁the 0.410400390625
▁study 2.68359375
▁used 1.3203125
▁multiple 5.26953125
▁log 0.6103515625
istic 0.02685546875
▁regression 0.297607421875
▁analysis 1.392578125
▁and 2.75
▁chose 8.5625
▁medical 6.25390625
▁mar 0.09423828125
iju 0.0010004043579101562
ana 3.981590270996094e-05
▁as 0.5537109375
▁the 0.873046875
▁control 2.8359375
▁group 0.61865234375
. 0.263916015625
<0x0A> 0.349365234375
This 4.0859375
▁type 5.79296875
▁of 0.00206756591796875
▁study 1.3955078125
▁is 1.287109375
▁the 3.623046875
▁most 1.26171875
▁reve 7.9765625
aling 0.0005035400390625
▁and 1.4619140625
▁inclus 7.03515625
ive 0.0007433891296386719
, 3.115234375
▁as 1.2548828125
▁it 0.341796875
▁contains 4.62890625
▁direct 5.984375
▁responses 5.51953125
▁from 0.5791015625
▁a 3.59375
▁large 0.90869140625
▁number 0.448974609375
▁of 0.0022716522216796875
▁participants 0.93701171875
. 0.53466796875
▁All 5.328125
▁tools 7.81640625
▁in 5.7578125
▁the 0.80419921875
▁form 3.9296875
▁of 0.019317626953125
▁question 0.7158203125
na 0.013702392578125
ires 0.00035309791564941406
▁and 1.2041015625
▁scales 2.6640625
▁have 3.435546875
▁already 3.935546875
▁been 0.41162109375
▁used 2.18359375
▁and 1.849609375
▁proved 2.369140625
▁their 1.4462890625
▁effic 2.5390625
acy 0.00276947021484375
▁for 3.578125
▁collect 4.01171875
ing 0.003559112548828125
▁analyt 7.25
ical 0.09228515625
▁data 0.1673583984375
. 0.335693359375
▁It 3.22265625
▁helps 4.23828125
▁to 0.6953125
▁system 6.96875
at 0.53955078125
ize 0.001697540283203125
▁and 1.2958984375
▁class 4.87890625
ify 0.0018663406372070312
▁distinct 8.1796875
▁kinds 6.37109375
▁of 0.0151214599609375
▁information 2.30078125
▁for 4.015625
▁subsequent 5.11328125
▁un 8.78125
comp 4.4296875
licated 0.024932861328125
▁services 12.59375
. 0.54443359375
▁Thus 4.76171875
, 0.003971099853515625
▁research 4.28515625
ers 0.2275390625
▁can 1.6474609375
▁compare 2.5
▁the 1.0224609375
▁effects 2.755859375
▁of 0.09307861328125
▁medic 3.75390625
ations 0.62451171875
▁on 1.6669921875
▁patients 2.005859375
▁of 4.2265625
▁diverse 2.984375
▁age 1.958984375
▁groups 2.28125
, 0.74169921875
▁background 3.703125
s 0.1141357421875
, 0.01214599609375
▁physical 5.69140625
▁conditions 1.3583984375
, 0.028594970703125
▁emot 6.38671875
ional 0.0305023193359375
▁states 1.345703125
, 0.03643798828125
▁and 0.3779296875
▁so 2.56640625
▁on 0.203125
. 0.0626220703125
<0x0A> 0.78271484375
The 0.7333984375
▁analysis 3.921875
▁of 0.67578125
▁any 9.4921875
▁human 6.98828125
▁reaction 4.03125
▁has 4.84375
▁a 1.8232421875
▁high 3.052734375
▁potential 3.173828125
▁of 2.0859375
▁subject 2.9140625
iveness 3.529296875
▁and 1.2978515625
▁bias 1.7724609375
, 2.0703125
▁especially 2.158203125
▁regarding 3.623046875
▁people 5.1171875
▁in 3.771484375
▁severe 2.65625
▁pain 0.6318359375
▁and 2.330078125
▁un 5.67578125
stable 0.8955078125
▁emot 0.64306640625
ional 0.080322265625
▁condition 2.521484375
. 0.0438232421875
▁Perhaps 8.28125
▁some 5.25390625
▁patients 1.9345703125
▁tend 4.70703125
▁to 0.0088958740234375
▁ex 2.046875
agger 0.00872039794921875
ate 0.0013322830200195312
▁their 0.96435546875
▁de 3.0234375
press 1.8134765625
ive 0.06451416015625
▁state 2.423828125
▁or 1.63671875
▁vice 5.91015625
▁vers 0.0238800048828125
a 3.7550926208496094e-05
, 1.056640625
▁de 7.44140625
- 2.517578125
emph 0.429931640625
as 0.0022335052490234375
ize 0.06182861328125
▁serious 6.76171875
▁difficulties 5.7109375
. 0.80908203125
▁Because 6.25
▁the 2.779296875
▁survey 5.13671875
▁responses 7.04296875
▁were 1.5751953125
▁thoroughly 8.5625
▁anonymous 3.13671875
, 0.2445068359375
▁the 1.2138671875
▁research 1.044921875
ers 0.1986083984375
▁were 2.611328125
▁unable 2.87109375
▁to 0.0011587142944335938
▁carefully 7.890625
▁analyze 2.60546875
▁each 2.431640625
▁patient 2.447265625
’ 0.58447265625
s 0.0005002021789550781
▁reaction 3.845703125
▁and 1.3349609375
▁compare 3.595703125
▁it 0.84912109375
▁to 0.64404296875
▁the 0.95849609375
▁actual 4.4375
▁states 7.6015625
▁of 0.75341796875
▁condition 6.7578125
. 0.300048828125
▁More 6.51171875
▁accurate 3.177734375
▁answers 4.40234375
▁could 1.8603515625
▁be 0.75244140625
▁obtained 1.0205078125
▁by 1.373046875
▁professional 5.953125
▁psych 1.1708984375
olog 0.38037109375
ists 0.00118255615234375
▁via 7.28515625
▁personal 2.60546875
▁communication 4.25
▁and 2.025390625
▁behavior 6.25
al 0.26123046875
▁analysis 1.9736328125
. 0.2384033203125
▁However 2.89453125
, 0.0002644062042236328
▁this 1.39453125
▁method 2.240234375
▁of 2.7109375
▁research 1.8095703125
▁is 1.1298828125
▁way 5.64453125
▁more 0.82861328125
▁resource 4.83203125
- 0.253173828125
int 1.44140625
ensive 0.0242462158203125
▁and 0.411376953125
▁energy 10.765625
- 0.0670166015625
consum 0.359130859375
ing 0.0017547607421875
. 0.67138671875
<0x0A> 0.37451171875
The 0.88525390625
▁study 1.291015625
▁conducted 4.46875
▁a 2.46875
▁correlation 6.62890625
▁type 9.3125
▁of 0.21533203125
▁research 0.921875
▁with 3.767578125
▁variable 8.78125
▁measures 5.4609375
. 0.88427734375
▁It 1.29296875
▁evaluated 4.74609375
▁the 0.56787109375
▁inter 6.4375
dep 2.310546875
end 0.0001951456069946289
ence 0.00811767578125
▁of 0.62451171875
▁various 3.44140625
▁factors 0.76220703125
▁that 3.00390625
▁affected 4.140625
▁the 0.409912109375
▁physical 6.609375
▁and 0.285888671875
▁emot 0.495849609375
ional 0.00014138221740722656
▁condition 1.5625
▁of 0.044647216796875
▁patients 0.7763671875
▁experien 3.60546875
cing 3.790855407714844e-05
▁chron 0.33837890625
ic 0.0002143383026123047
▁pain 0.027069091796875
. 0.11944580078125
▁For 4.30078125
▁example 0.98193359375
, 0.0009617805480957031
▁the 1.0234375
▁survey 5.6015625
▁showed 3.5078125
▁that 0.5068359375
▁the 1.8330078125
▁ratio 6.96875
▁of 0.130859375
▁female 3.607421875
▁patients 1.0810546875
▁was 1.3955078125
▁remark 7.66015625
ably 0.0001895427703857422
▁higher 0.1861572265625
▁in 2.970703125
▁the 0.7041015625
▁op 3.904296875
i 2.29296875
ates 0.00933837890625
▁group 0.1170654296875
▁compared 2.458984375
▁to 0.03253173828125
▁the 0.6318359375
▁MM 0.25439453125
▁group 0.61767578125
. 0.1785888671875
▁In 3.71484375
▁turn 3.3828125
, 0.0007176399230957031
▁people 4.62109375
▁on 4.51171875
▁op 2.21875
i 0.295166015625
ates 0.002170562744140625
▁were 1.0322265625
▁more 1.1767578125
▁likely 0.307861328125
▁to 0.0175628662109375
▁report 2.623046875
▁major 6.09765625
▁de 0.439697265625
press 0.828125
ive 0.0033779144287109375
▁dis 1.1455078125
orders 1.4306640625
. 1.3857421875
<0x0A> 2.396484375
Am 5.890625
ong 0.01514434814453125
▁all 2.466796875
▁participants 2.171875
▁in 3.091796875
▁the 0.262451171875
▁study 0.9716796875
, 0.052642822265625
▁ 1.5458984375
4 2.091796875
2 2.302734375
. 0.982421875
2 2.25
% 0.0989990234375
▁suffered 3.490234375
▁from 0.05352783203125
▁de 1.3271484375
pression 0.2078857421875
, 1.0595703125
▁and 0.9052734375
▁ 0.208740234375
3 1.29296875
7 2.314453125
% 2.5390625
▁experienced 2.2890625
▁excess 6.70703125
ive 0.0291290283203125
▁anx 0.20068359375
iety 0.0021457672119140625
. 0.1600341796875
▁The 1.4990234375
▁pl 11.09375
ur 0.5390625
ality 0.00058746337890625
▁of 0.09259033203125
▁de 2.6171875
press 1.244140625
ive 0.038330078125
▁dis 2.640625
orders 0.06036376953125
▁among 2.66796875
▁patients 1.4365234375
▁in 2.873046875
▁the 0.2890625
▁op 0.5009765625
i 0.2037353515625
ates 0.0014600753784179688
, 9.609375
▁medical 4.83203125
▁mar 0.0843505859375
iju 0.0008616447448730469
ana 4.3272972106933594e-05
, 0.33203125
▁and 0.11614990234375
▁mixed 3.85546875
▁OP 11.6171875
MM 6.6171875
▁groups 0.576171875
▁number 9.3125
ed 0.0238189697265625
▁ 0.2216796875
5 2.041015625
7 2.58984375
. 0.499755859375
1 2.6171875
%, 0.2325439453125
▁ 0.004016876220703125
2 1.78515625
2 2.4296875
. 0.1641845703125
3 2.361328125
%, 0.05029296875
▁and 0.05816650390625
▁ 0.00241851806640625
5 2.400390625
1 2.2109375
. 0.1744384765625
4 2.1640625
%, 0.163330078125
▁respectively 0.02935791015625
. 0.04437255859375
▁The 1.2900390625
▁pl 4.6484375
ur 0.0116119384765625
ality 3.147125244140625e-05
▁of 0.0296630859375
▁anx 0.455078125
iety 0.0208892822265625
▁contained 10.4296875
▁ 0.2108154296875
4 1.20703125
8 2.298828125
. 0.21337890625
4 2.212890625
% 2.12109375
▁among 2.673828125
▁OP 4.62109375
▁patients 5.859375
, 0.331298828125
▁ 0.10772705078125
2 1.09375
1 2.5234375
. 0.1407470703125
5 2.291015625
% 0.0228271484375
▁among 0.5869140625
▁MM 0.09710693359375
▁patients 0.486083984375
, 0.02197265625
▁and 0.02239990234375
▁ 0.034912109375
3 1.5703125
8 1.9189453125
. 0.1436767578125
7 2.19921875
% 0.0124664306640625
▁among 0.2071533203125
▁OP 2.646484375
MM 0.1751708984375
▁participants 3.53125
. 0.030487060546875
▁Pat 5.79296875
ients 0.01471710205078125
▁who 2.3125
▁took 3.11328125
▁strong 9.21875
▁op 0.7548828125
i 0.68115234375
ates 0.0031585693359375
▁were 1.212890625
▁t 10.0234375
ended 1.1328125
▁to 0.007160186767578125
▁place 9.9609375
▁their 2.26171875
▁pain 3.04296875
▁on 1.7880859375
▁a 0.85595703125
▁scale 2.525390625
▁of 0.34375
▁ 0.1767578125
9 2.189453125
▁to 2.306640625
▁ 0.011322021484375
1 0.0075836181640625
0 0.055267333984375
▁( 3.109375
Fe 10.59375
ing 2.173828125
old 0.7216796875
▁et 1.5849609375
▁al 0.01373291015625
., 0.1715087890625
▁ 0.0176544189453125
2 0.0738525390625
0 0.00035071372985839844
1 0.2210693359375
7 1.7021484375
). 0.064208984375
▁They 4.33203125
▁were 1.6884765625
▁also 1.056640625
▁an 9.546875
gu 3.94921875
ished 0.07708740234375
▁em 6.5078125
otion 0.0013952255249023438
ally 0.0006146430969238281
▁and 0.97802734375
▁react 7.2734375
ed 0.01995849609375
▁rad 8.8828125
ically 0.0007867813110351562
▁neg 5.00390625
atively 0.0013170242309570312
▁to 0.19873046875
▁almost 5.484375
▁all 1.6376953125
▁survey 4.11328125
▁questions 0.249755859375
. 0.37939453125
▁Pat 3.732421875
ients 0.00543975830078125
▁who 1.3017578125
▁took 1.740234375
▁only 5.02734375
▁MM 0.39404296875
▁or 2.1875
▁mixed 2.05078125
▁medic 1.5205078125
ations 0.32763671875
▁course 13.6640625
▁had 2.712890625
▁a 1.384765625
▁significantly 2.9921875
▁more 2.6953125
▁stable 2.541015625
▁emot 0.85009765625
ional 0.0009670257568359375
▁state 0.6240234375
▁and 1.103515625
▁cop 6.73046875
ed 0.0266571044921875
▁with 0.303955078125
▁pain 0.876953125
▁more 1.8955078125
▁manage 6.52734375
able 1.3720703125
. 0.290283203125
<0x0A> 0.2607421875
Part 5.3828125
icip 0.1807861328125
ants 0.047027587890625
▁were 3.255859375
▁rec 3.125
ru 0.0006909370422363281
ited 7.450580596923828e-05
▁for 1.689453125
▁six 0.492431640625
▁months 0.007556915283203125
▁at 0.6015625
▁two 0.094970703125
▁major 0.1422119140625
▁pain 0.0418701171875
▁relief 0.032257080078125
▁cent 0.0142364501953125
ers 0.0005202293395996094
▁in 0.0489501953125
▁Israel 0.01099395751953125
. 0.1552734375
▁All 4.109375
▁patients 1.3134765625
▁experienced 3.244140625
▁chron 0.80517578125
ic 0.0001633167266845703
▁pain 0.151611328125
▁for 2.1328125
▁at 0.650390625
▁least 0.0023670196533203125
▁ 1.6416015625
3 1.5107421875
▁months 0.2325439453125
. 1.1318359375
▁The 1.408203125
▁study 1.619140625
▁included 2.046875
▁ 0.59716796875
8 3.0625
9 2.42578125
0 2.90234375
▁participants 1.5693359375
, 1.4541015625
▁of 2.58984375
▁which 0.447998046875
▁ 0.1021728515625
4 1.5439453125
7 2.388671875
4 2.708984375
▁( 3.0078125
5 0.1014404296875
9 5.0703125
%) 1.0302734375
▁were 0.76611328125
▁treated 4.40234375
▁sole 5.41796875
ly 0.0003330707550048828
▁with 0.2220458984375
▁op 0.94873046875
io 0.98974609375
ids 0.1854248046875
, 0.406494140625
▁ 0.204345703125
3 1.369140625
2 2.193359375
9 2.609375
▁( 0.0335693359375
4 2.39453125
1 1.40625
%) 0.07159423828125
▁were 1.580078125
▁treated 0.467041015625
▁with 0.441162109375
▁MM 0.6396484375
, 0.277099609375
▁and 0.0770263671875
▁ 0.11444091796875
7 2.380859375
7 1.609375
▁( 0.08447265625
8 1.8525390625
. 0.8447265625
6 2.7421875
%) 0.03662109375
▁acquired 10.3203125
▁both 0.82177734375
▁( 3.595703125
Fe 0.390625
ing 0.00263214111328125
old 0.00032448768615722656
▁et 0.0130157470703125
▁al 0.0008192062377929688
., 0.007198333740234375
▁ 0.0008411407470703125
2 0.0001239776611328125
0 2.4199485778808594e-05
1 0.0011739730834960938
7 0.00853729248046875
). 0.005218505859375
▁The 1.150390625
▁remaining 7.41796875
▁ten 6.9375
▁participants 1.19140625
▁who 4.74609375
▁did 2.583984375
▁not 0.0074462890625
▁receive 2.486328125
▁ph 4.55078125
arma 0.1246337890625
ce 0.0009889602661132812
ut 1.5497207641601562e-06
ical 0.0027027130126953125
▁op 2.49609375
io 0.3076171875
ids 0.0243682861328125
▁and 2.578125
▁medical 1.4912109375
▁mar 0.0291748046875
iju 0.00027871131896972656
ana 4.887580871582031e-05
▁were 0.61181640625
▁with 6.91015625
dra 0.03887939453125
wn 7.867813110351562e-06
▁from 0.21875
▁the 0.1806640625
▁analysis 2.353515625
▁in 5.25390625
▁the 0.88623046875
▁research 4.32421875
. 0.7724609375
▁Therefore 5.3828125
, 0.007518768310546875
▁it 3.603515625
▁is 1.220703125
▁not 2.859375
▁possible 0.76220703125
▁to 0.004772186279296875
▁compreh 5.8515625
ens 0.1536865234375
ively 0.0238037109375
▁compare 1.376953125
▁patients 4.66796875
▁taking 2.88671875
▁medic 3.9453125
ations 0.360107421875
▁with 1.4384765625
▁those 1.2236328125
▁who 0.634765625
▁do 1.9140625
▁not 0.00432586669921875
. 0.5849609375
<0x0A> 0.611328125
The 0.80078125
▁question 5.3203125
na 0.775390625
ires 5.733966827392578e-05
▁used 1.7998046875
▁different 8.0
▁variable 9.1796875
▁measures 0.498046875
▁to 1.8701171875
▁collect 2.73046875
▁information 1.6650390625
. 1.2333984375
▁For 1.888671875
▁example 0.1954345703125
, 0.0010175704956054688
▁it 3.810546875
▁included 1.9345703125
▁compreh 8.5234375
ensive 0.05877685546875
▁so 5.890625
cio 0.0019702911376953125
- 0.1971435546875
dem 0.08160400390625
ographic 0.071533203125
▁data 0.943359375
: 4.92578125
▁gender 2.103515625
, 0.050750732421875
▁age 0.2369384765625
, 0.03790283203125
▁country 4.265625
, 2.490234375
▁type 4.3515625
▁of 0.0621337890625
▁residence 3.962890625
▁( 2.62890625
urban 0.6669921875
/ 1.47265625
r 0.1676025390625
ural 0.0009493827819824219
), 0.1590576171875
▁years 6.26953125
▁of 0.1478271484375
▁education 0.662109375
, 0.0865478515625
▁and 1.435546875
▁employ 2.560546875
ment 0.0020694732666015625
▁status 0.7421875
. 0.1927490234375
▁Pat 4.1875
ients 0.0771484375
▁were 1.0693359375
▁also 0.71630859375
▁asked 0.56591796875
▁about 1.048828125
▁their 0.6943359375
▁medical 2.80078125
▁history 0.5302734375
▁over 8.7265625
▁the 0.06298828125
▁years 4.703125
▁and 1.6630859375
▁the 1.4677734375
▁current 3.130859375
▁presence 5.10546875
▁of 0.08624267578125
▁any 2.302734375
▁severe 3.63671875
▁dise 1.8203125
ases 9.763240814208984e-05
▁such 4.5546875
▁as 0.0010280609130859375
▁heart 2.642578125
▁failure 1.724609375
, 0.255615234375
▁di 1.6513671875
ab 0.0008106231689453125
etes 0.0025615692138671875
, 0.0670166015625
▁ar 4.19140625
th 0.1790771484375
rit 0.0302886962890625
is 0.005069732666015625
, 0.0223236083984375
▁and 1.19140625
▁so 0.81298828125
▁on 0.0592041015625
. 0.055328369140625
▁The 1.5751953125
▁third 7.01953125
▁measure 3.75390625
▁of 2.48046875
▁the 0.650390625
▁question 1.5048828125
naire 0.18310546875
▁was 1.2421875
▁indicated 10.71875
▁by 1.42578125
▁information 6.88671875
▁on 2.078125
▁any 5.93359375
▁twelve 14.1796875
- 0.2303466796875
month 0.2054443359375
▁and 4.95703125
▁lifetime 0.69189453125
▁drug 3.57421875
▁and 1.6796875
▁alco 0.1116943359375
hol 7.545948028564453e-05
▁consumption 4.15234375
. 0.4453125
▁In 3.5703125
▁addition 0.88525390625
, 0.193359375
▁the 1.048828125
▁record 10.4453125
▁included 1.416015625
▁a 2.712890625
▁pain 3.986328125
▁measurement 4.9453125
▁scale 0.5146484375
▁from 2.861328125
▁ 0.207763671875
0 0.322998046875
▁to 0.143798828125
▁ 0.004436492919921875
1 0.0143890380859375
0 0.0167083740234375
▁to 3.88671875
▁evaluate 1.306640625
▁dis 6.4375
com 0.08905029296875
fort 0.0013580322265625
▁feelings 7.67578125
▁during 4.3046875
▁the 0.271728515625
▁last 1.0400390625
▁month 1.7998046875
. 0.270751953125
<0x0A> 0.802734375
One 5.14453125
▁of 0.2235107421875
▁the 0.005352020263671875
▁major 3.099609375
▁limitations 2.431640625
▁is 2.681640625
▁the 0.46923828125
▁ins 4.82421875
u 0.060882568359375
fficient 0.072265625
ly 3.296875
▁high 3.05078125
▁response 3.125
▁rate 0.0880126953125
, 2.751953125
▁ 4.4296875
5 1.716796875
7 2.572265625
% 1.8994140625
▁instead 6.78125
▁of 0.0023136138916015625
▁ 0.517578125
7 1.373046875
0 0.4580078125
% 1.294921875
▁( 1.640625
Fe 0.314697265625
ing 0.0017328262329101562
old 0.0002777576446533203
▁et 0.007091522216796875
▁al 0.0002090930938720703
., 0.004852294921875
▁ 0.0006151199340820312
2 7.450580596923828e-05
0 9.703636169433594e-05
1 0.00027942657470703125
7 0.0025424957275390625
). 0.007720947265625
▁It 1.7529296875
▁can 3.138671875
▁be 0.72119140625
▁fairly 8.390625
▁explained 1.5419921875
▁by 0.1961669921875
▁the 0.286376953125
▁weak 7.75390625
▁focus 6.875
▁of 0.73388671875
▁respond 5.5703125
ents 0.1097412109375
▁who 3.486328125
▁have 3.845703125
▁overcome 8.3828125
▁severe 1.9658203125
▁pain 0.47998046875
▁sens 7.75390625
ations 0.2003173828125
▁and 0.92529296875
▁de 4.86328125
press 0.86279296875
ive 0.04559326171875
▁episodes 2.26171875
. 0.485107421875
▁It 2.814453125
▁is 0.73193359375
▁not 2.572265625
▁clear 3.650390625
▁how 1.9541015625
▁to 3.640625
▁use 5.47265625
▁these 2.943359375
▁statistics 4.08203125
, 2.873046875
▁as 0.68115234375
▁they 1.9912109375
▁still 5.1875
▁may 4.65625
▁be 1.4912109375
▁relevant 4.953125
▁for 1.7119140625
▁the 1.6953125
▁overall 4.5703125
▁analysis 2.33984375
. 0.705078125
